Stephane Bancel Moderna, Inc. (MRNA) insider trading activity

Stephane Bancel is Chief Executive Officer of Moderna, Inc.. Currently has a direct ownership of 5.49 Million shares of MRNA, which is worth approximately $156 Million. The most recent transaction as insider was on Mar 10, 2020, when has been sold 4,117 shares (Common Stock) at a price of $25.71 per share, resulting in proceeds of $105,848. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.49M

0.12% 3M change

0.62% 12M change

Total Value Held $156 Million

Stephane Bancel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 10 2020	SELL Open market or private sale	$105,848 $25.71 p/Share	4,117 Reduced 0.06%	6,714,674 Common Stock
Mar 02 2020	SELL Open market or private sale	$104,486 $27.09 p/Share	3,857 Reduced 0.06%	6,718,791 Common Stock
Feb 25 2020	SELL Open market or private sale	$121,578 $23.0 p/Share	5,286 Reduced 0.08%	6,722,648 Common Stock
Feb 18 2020	SELL Bona fide gift	-	5,000 Reduced 0.07%	6,727,934 Common Stock
Feb 10 2020	SELL Open market or private sale	$101,120 $23.5 p/Share	4,303 Reduced 0.06%	6,732,934 Common Stock
Feb 07 2020	SELL Open market or private sale	$112,148 $23.0 p/Share	4,876 Reduced 0.07%	6,737,237 Common Stock
Jan 22 2020	SELL Open market or private sale	$354,154 $23.0 p/Share	15,398 Reduced 0.23%	6,742,113 Common Stock
Jan 15 2020	SELL Bona fide gift	-	4,989 Reduced 0.07%	6,757,511 Common Stock
Dec 09 2019	BUY Other acquisition or disposition	-	42,132 Added 0.62%	6,762,500 Common Stock

Stephane Bancel

Chief Executive Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account